Indivior PLC (LON:INDV – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,020.41 ($13.28) and traded as low as GBX 773.50 ($10.07). Indivior shares last traded at GBX 789.50 ($10.28), with a volume of 693,400 shares.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,500 ($19.53) target price on shares of Indivior in a report on Thursday, September 5th.
View Our Latest Stock Analysis on INDV
Indivior Stock Down 0.3 %
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
See Also
- Five stocks we like better than Indivior
- What Are the U.K. Market Holidays? How to Invest and Trade
- California Resources Stock Could Be a Huge Long-Term Winner
- The 3 Best Retail Stocks to Shop for in August
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- What is the Hang Seng index?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.